Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mylicon
- Development stage
- Unknown
- Lead developer
- Infirst Healthcare
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Mylicon is a portfolio of over-the-counter (OTC) healthcare products commercialized by Infirst Healthcare, specifically designed for the relief of gastrointestinal discomfort in infants and children. The primary product, Infants' Mylicon Gas Relief Drops, contains simethicone, a non-systemic anti-foaming agent that works by reducing the surface tension of gas bubbles in the digestive tract, allowing them to be expelled more easily. The portfolio also includes Infants' Mylicon Daily Probiotic Drops, which are intended to support digestive health and manage symptoms of colic and fussiness by balancing the gut microbiota. These products are formulated without alcohol, artificial flavors, or gluten, and are marketed as pediatrician-recommended solutions for infant gas and colic-related discomfort.
- Brand names
- MyliconInfants' Mylicon Gas Relief DropsInfants' Mylicon Daily Probiotic DropsChildren's Mylicon Tummy Relief
- Other names
- simethiconeprobiotics
Beyond the preview
Go deeper on Mylicon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mylicon.